FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078411289> ?p ?o ?g. }

• W2078411289 endingPage "2099" @default.
• W2078411289 startingPage "2092" @default.
• W2078411289 abstract "In situ evaluation of podocin in normal and glomerular diseases.BackgroundMutations of the NPHS2 gene are responsible for autosomal-recessive steroid-resistant nephrotic syndrome. Its product, podocin, faces the slit diaphragm area with its two ends in the cytoplasm of foot processes.MethodsWe generated rabbit polyclonal antibodies against conjugated peptides from human podocin N- and C-termini, and studied podocin and synaptopodin using kidney tissues of normal humans and those with glomerular diseases.ResultsAntipodocin antibodies detected the original 42 kD fragment and an extra smaller fragment by Western blot analysis using human isolated mature glomeruli. RNA analysis showed two bands, the original and the other of a decreased length. Immunohistochemically, podocin was detected in a linear pattern along the glomerular capillary loop. Antipodocin antibody (C-terminal) stained the smooth muscles of renal arterioles and aorta. Among 42 patients, podocin was normally expressed in glomeruli in purpura nephritis, IgA nephropathy (IgAN), and minimal-change disease (MCD), while it was either decreased or absent in most subjects with focal segmental glomerulosclerosis (FSGS). The expression of synaptopodin was similar to that of podocin, although some discrepancy existed.ConclusionAlthough indirect, our data suggest the existence of a vascular isoform of podocin with a different molecular mass. We propose that examination of podocin expression may help differentiate MCD from FSGS. In situ evaluation of podocin in normal and glomerular diseases. Mutations of the NPHS2 gene are responsible for autosomal-recessive steroid-resistant nephrotic syndrome. Its product, podocin, faces the slit diaphragm area with its two ends in the cytoplasm of foot processes. We generated rabbit polyclonal antibodies against conjugated peptides from human podocin N- and C-termini, and studied podocin and synaptopodin using kidney tissues of normal humans and those with glomerular diseases. Antipodocin antibodies detected the original 42 kD fragment and an extra smaller fragment by Western blot analysis using human isolated mature glomeruli. RNA analysis showed two bands, the original and the other of a decreased length. Immunohistochemically, podocin was detected in a linear pattern along the glomerular capillary loop. Antipodocin antibody (C-terminal) stained the smooth muscles of renal arterioles and aorta. Among 42 patients, podocin was normally expressed in glomeruli in purpura nephritis, IgA nephropathy (IgAN), and minimal-change disease (MCD), while it was either decreased or absent in most subjects with focal segmental glomerulosclerosis (FSGS). The expression of synaptopodin was similar to that of podocin, although some discrepancy existed. Although indirect, our data suggest the existence of a vascular isoform of podocin with a different molecular mass. We propose that examination of podocin expression may help differentiate MCD from FSGS." @default.
• W2078411289 created "2016-06-24" @default.
• W2078411289 creator A5012313910 @default.
• W2078411289 creator A5054392428 @default.
• W2078411289 creator A5057507796 @default.
• W2078411289 creator A5070062899 @default.
• W2078411289 creator A5072987613 @default.
• W2078411289 creator A5073808677 @default.
• W2078411289 creator A5076630336 @default.
• W2078411289 creator A5082262899 @default.
• W2078411289 creator A5084458138 @default.
• W2078411289 creator A5084806256 @default.
• W2078411289 date "2003-12-01" @default.
• W2078411289 modified "2023-09-25" @default.
• W2078411289 title "In situ evaluation of podocin in normal and glomerular diseases" @default.
• W2078411289 cites W1966275916 @default.
• W2078411289 cites W1971573514 @default.
• W2078411289 cites W1980065732 @default.
• W2078411289 cites W2005043762 @default.
• W2078411289 cites W2018215777 @default.
• W2078411289 cites W2023116194 @default.
• W2078411289 cites W2041865085 @default.
• W2078411289 cites W2046540619 @default.
• W2078411289 cites W2054225562 @default.
• W2078411289 cites W2077689651 @default.
• W2078411289 cites W2103406587 @default.
• W2078411289 cites W2110230080 @default.
• W2078411289 cites W2129416468 @default.
• W2078411289 cites W2133176024 @default.
• W2078411289 cites W2133691034 @default.
• W2078411289 cites W2135679847 @default.
• W2078411289 cites W2136102149 @default.
• W2078411289 cites W4231951653 @default.
• W2078411289 cites W4294216491 @default.
• W2078411289 doi "https://doi.org/10.1046/j.1523-1755.2003.00303.x" @default.
• W2078411289 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14633131" @default.
• W2078411289 hasPublicationYear "2003" @default.
• W2078411289 type Work @default.
• W2078411289 sameAs 2078411289 @default.
• W2078411289 citedByCount "37" @default.
• W2078411289 countsByYear W20784112892012 @default.
• W2078411289 countsByYear W20784112892013 @default.
• W2078411289 countsByYear W20784112892014 @default.
• W2078411289 countsByYear W20784112892015 @default.
• W2078411289 countsByYear W20784112892016 @default.
• W2078411289 countsByYear W20784112892017 @default.
• W2078411289 countsByYear W20784112892018 @default.
• W2078411289 countsByYear W20784112892019 @default.
• W2078411289 countsByYear W20784112892020 @default.
• W2078411289 countsByYear W20784112892021 @default.
• W2078411289 crossrefType "journal-article" @default.
• W2078411289 hasAuthorship W2078411289A5012313910 @default.
• W2078411289 hasAuthorship W2078411289A5054392428 @default.
• W2078411289 hasAuthorship W2078411289A5057507796 @default.
• W2078411289 hasAuthorship W2078411289A5070062899 @default.
• W2078411289 hasAuthorship W2078411289A5072987613 @default.
• W2078411289 hasAuthorship W2078411289A5073808677 @default.
• W2078411289 hasAuthorship W2078411289A5076630336 @default.
• W2078411289 hasAuthorship W2078411289A5082262899 @default.
• W2078411289 hasAuthorship W2078411289A5084458138 @default.
• W2078411289 hasAuthorship W2078411289A5084806256 @default.
• W2078411289 hasBestOaLocation W20784112891 @default.
• W2078411289 hasConcept C126322002 @default.
• W2078411289 hasConcept C134018914 @default.
• W2078411289 hasConcept C142724271 @default.
• W2078411289 hasConcept C153911025 @default.
• W2078411289 hasConcept C185592680 @default.
• W2078411289 hasConcept C2775946357 @default.
• W2078411289 hasConcept C2776855237 @default.
• W2078411289 hasConcept C2777146197 @default.
• W2078411289 hasConcept C2778415529 @default.
• W2078411289 hasConcept C2778930706 @default.
• W2078411289 hasConcept C2779561371 @default.
• W2078411289 hasConcept C2780091579 @default.
• W2078411289 hasConcept C2780368995 @default.
• W2078411289 hasConcept C2910727860 @default.
• W2078411289 hasConcept C3018201436 @default.
• W2078411289 hasConcept C71924100 @default.
• W2078411289 hasConcept C86803240 @default.
• W2078411289 hasConceptScore W2078411289C126322002 @default.
• W2078411289 hasConceptScore W2078411289C134018914 @default.
• W2078411289 hasConceptScore W2078411289C142724271 @default.
• W2078411289 hasConceptScore W2078411289C153911025 @default.
• W2078411289 hasConceptScore W2078411289C185592680 @default.
• W2078411289 hasConceptScore W2078411289C2775946357 @default.
• W2078411289 hasConceptScore W2078411289C2776855237 @default.
• W2078411289 hasConceptScore W2078411289C2777146197 @default.
• W2078411289 hasConceptScore W2078411289C2778415529 @default.
• W2078411289 hasConceptScore W2078411289C2778930706 @default.
• W2078411289 hasConceptScore W2078411289C2779561371 @default.
• W2078411289 hasConceptScore W2078411289C2780091579 @default.
• W2078411289 hasConceptScore W2078411289C2780368995 @default.
• W2078411289 hasConceptScore W2078411289C2910727860 @default.
• W2078411289 hasConceptScore W2078411289C3018201436 @default.
• W2078411289 hasConceptScore W2078411289C71924100 @default.
• W2078411289 hasConceptScore W2078411289C86803240 @default.
• W2078411289 hasIssue "6" @default.
• W2078411289 hasLocation W20784112891 @default.

• next